Application of implantable venous infusion port in the treatment of patients with malignant tumors
植入式静脉输液港在恶性肿瘤患者治疗中的应用分析

摘要

目的 分析植入式静脉输液港在恶性肿瘤患者治疗中的应用效果。方法 本次研究对象选取2022年11月至2024年11月期间我院接收的恶性肿瘤患者80例,采用随机数字表法将入选的80例患者分成两组开展护理治疗研究，其中包括观察组40例和对照组40例。治疗期间对照组患者给予经外周静脉穿刺中心静脉置管(PICC)，观察组给予植入式静脉输液港，分析对比两组取得的护理治疗效果。结果 对比分析结果显示，观察组一次性置管成功率、3个月及半年的导管留置率均高于对照组，意外拔管率和并发症发生率均低于对照组，导管维护时间短于对照组，且导管留置时间显著长于对照组，（P<0.05）。结论 在恶性肿瘤患者管理中实施植入式静脉输液港护理，能够有效提高一次穿刺成功率和导管使用寿命，减少导管相关并发症发生。

Abstract

Objective To analyze the application effect of implantable intravenous infusion port in the treatment of patients with malignant tumors.
Methods The study object selected 80 patients with malignant tumors from November 2022 to November 2024, and the 80 patients were divided into two groups for nursing treatment study, including 40 patients in the observation group and 40 patients in the control group. During the treatment period, the control group was given central venous catheterization (PICC) through peripheral venipuncture, and the observation group was given the implantable intravenous infusion port, analyzing and comparing the nursing treatment effect of the two groups.
Results The comparative analysis results showed that the success rate of single catheterization, catheter retention rate of 3 months and half months in the observation group were higher than that of the control group, the accidental extubation rate and complication rate were lower than the control group, the catheter maintenance time was shorter than that of the control group, and the catheter retention time was significantly longer than that of the control group, (P <0.05).
Conclusion   The implementation of implantable intravenous infusion port care in the management of malignant tumor patients can effectively improve the success rate of primary puncture and catheter service life, and reduce the occurrence of catheter-related complications.